Literature DB >> 10822375

Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.

A H Ma1, L Xia, S J Littman, S Swinler, G Lader, A Polinkovsky, J Olechnowicz, L Kasturi, J Lutterbaugh, P Modrich, M L Veigl, S D Markowitz, W D Sedwick.   

Abstract

Inactivation of DNA-mismatch repair underlies the genesis of microsatellite unstable (MSI) colon cancers. hPMS2 is one of several genes encoding components of the DNA-mismatch repair complex, and germline hPMS2 mutations have been found in a few kindreds with hereditary nonpolyposis colorectal carcinoma (HNPCC), in whom hereditary MSI colon cancers develop. However, mice bearing null hPMS2 genes do not develop colon cancers and hPMS2 mutations in sporadic human colon cancers have not been described. Here we report that in Vaco481 colon cancer the hPMS2 gene is inactivated by somatic mutations of both hPMS2 alleles. The cell line derived from this tumor is functionally deficient in DNA mismatch repair. This deficiency can be biochemically complemented by addition of a purified hMLH1-hPMS2 (hMutLalpha) complex. The hPMS2 deficient Vaco481 cancer cell line demonstrates microsatellite instability, an elevated HPRT gene mutation rate, and resistance to the cytotoxicity of the alkylator MNNG. We conclude that somatic inactivation of hPMS2 can play a role in development of sporadic MSI colon cancer expressing the full range of cancer phenotypes associated with inactivation of the mismatch repair system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822375     DOI: 10.1038/sj.onc.1203568

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods.

Authors:  Sanjeevani Arora; Peter J Huwe; Rahmat Sikder; Manali Shah; Amanda J Browne; Randy Lesh; Emmanuelle Nicolas; Sanat Deshpande; Michael J Hall; Roland L Dunbrack; Erica A Golemis
Journal:  Cancer Biol Ther       Date:  2017-05-11       Impact factor: 4.742

2.  Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition.

Authors:  Rona Yaeger; Zhan Yao; David M Hyman; Jaclyn F Hechtman; Efsevia Vakiani; HuiYong Zhao; Wenjing Su; Lu Wang; Andrew Joelson; Andrea Cercek; Jose Baselga; Elisa de Stanchina; Leonard Saltz; Michael F Berger; David B Solit; Neal Rosen
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

3.  Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Authors:  J Young; L A Simms; K G Biden; C Wynter; V Whitehall; R Karamatic; J George; J Goldblatt; I Walpole; S A Robin; M M Borten; R Stitz; J Searle; D McKeone; L Fraser; D R Purdie; K Podger; R Price; R Buttenshaw; M D Walsh; M Barker; B A Leggett; J R Jass
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 4.  Endonuclease activities of MutLα and its homologs in DNA mismatch repair.

Authors:  Lyudmila Y Kadyrova; Farid A Kadyrov
Journal:  DNA Repair (Amst)       Date:  2015-12-02

5.  Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.

Authors:  Florian M Corvinus; Carina Orth; Richard Moriggl; Svetlana A Tsareva; Stefan Wagner; Edith B Pfitzner; Daniela Baus; Roland Kaufmann; Lukas A Huber; Kurt Zatloukal; Hartmut Beug; Peter Ohlschläger; Alexander Schütz; Karl-Jürgen Halbhuber; Karlheinz Friedrich
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

6.  Colorectal carcinoma: Pathologic aspects.

Authors:  Matthew Fleming; Sreelakshmi Ravula; Sergei F Tatishchev; Hanlin L Wang
Journal:  J Gastrointest Oncol       Date:  2012-09

7.  Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.

Authors:  Gian Luca Negri; Bruno M Grande; Alberto Delaidelli; Amal El-Naggar; Dawn Cochrane; Ching C Lau; Timothy J Triche; Richard A Moore; Steven Jm Jones; Alexandre Montpetit; Marco A Marra; David Malkin; Ryan D Morin; Poul H Sorensen
Journal:  J Pathol       Date:  2019-08-28       Impact factor: 9.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.